Effect of Symbicort on Sleep Quality in Patients With Emphysema
Status:
Unknown status
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study will look at the effects of the drug Symbicort on sleep quality. Symbicort is an
inhaled medication that contains 2 drugs. One is a medication that opens up the airways
(formoterol). The other is a steroid to decrease airway inflammation (budesonide). Symbicort
is not an experimental medication. It is approved by the Food and Drug Administration for use
in patients with emphysema. Patients with severe emphysema commonly sleep poorly. The cause
of poor sleep in these patients is unknown. Symbicort may improve sleep quality by opening
the airways and reducing lung inflammation. It is not known for sure if these effects
actually improve sleep and quality of life. It is hoped that this study will answer this
question.
Phase:
Phase 3
Details
Lead Sponsor:
Temple University
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate